A traditional Chinese medicinal root, Polygonum multiflorum, is gaining scientific attention for its potential to treat hair loss. This herb has been used for over one thousand years. It may offer a multi-pronged approach to combating androgenetic alopecia, also known as male or female pattern hair loss.
Androgenetic alopecia is the most common type of hair loss. It affects millions globally. Current treatments like finasteride and minoxidil have limitations. Some patients experience side effects. These include sexual side effects from finasteride or scalp irritation from minoxidil.
Researchers suggest Polygonum multiflorum may influence several processes related to hair loss and regrowth. The herb could block harmful hormones that shrink hair follicles. It may also activate signals important for hair growth. These include the Wnt and Shh pathways. Additionally, it might protect follicles and improve blood flow to the scalp.
This analysis combines ancient knowledge with modern scientific understanding. Historical texts from the Tang Dynasty describe effects that align with current hair biology. Modern studies are now confirming these traditional claims. This suggests a pharmacological basis for the herb's observed benefits.
The review emphasizes that proper processing of Polygonum multiflorum is crucial. This step affects both its safety and biological activity. When correctly prepared, the herb shows a favorable safety profile. This could make it a more acceptable option for some patients.
More clinical testing is needed to confirm the herb's effectiveness and safety. Current support comes from laboratory studies, historical records, and limited observations. Large-scale human trials are necessary to validate these findings for androgenetic alopecia patients.
Related stories
Dreaming May Deplete Brain Energy Despite Increased Fuel Supply
New research indicates that dreaming during REM sleep may consume significant brain energy, with neuronal energy levels dropping despite an increase in the brain's fuel supply.
Tirzepatide May Activate Calorie-Burning Brown Fat
A mouse study suggests tirzepatide, sold as Mounjaro and Zepbound, may activate calorie-burning brown fat, offering a new understanding of its metabolic benefits.
ADHD and Autism Diagnoses Show Shifting Demographics in Denmark
A large Danish study found that children diagnosed with ADHD or autism now more closely resemble the general population, suggesting broader identification rather than only an increase in underlying conditions.